Semax
ACTH(4-10) analog
Semax is a nootropic peptide with something almost no other research peptide has: a decades-long track record as an actual approved pharmaceutical. Developed in Russia in the 1980s and registered there since 1994, it's used as a nasal spray for cognition, stroke recovery and focus. This guide covers how Semax works, what the research shows, dosing references, its unusually clean safety profile, and status.
Semax quick facts
| Reported research dosing | 200mcg-800mcg |
| Route | Subq |
| Cycle length | 4-8 Weeks |
| Frequency | 1-2x Daily Am/Mid Day · 5 On 2 Off or Daily |
| Half-life | ~30-50 min (intranasal) |
| Forms | Injectable, Nasal |
| Evidence level | Russian human studies + animal |
Clean focus without stimulant jitter. Intranasal is popular; injectable hits harder.
How Semax works
Semax is a synthetic heptapeptide derived from ACTH (4-10) — but engineered to keep the cognitive effects while removing the stress-hormone (steroidogenic) activity of its parent. Its headline mechanism is rapid upregulation of BDNF (brain-derived neurotrophic factor) and its TrkB receptor in the hippocampus — BDNF is essentially fertilizer for neurons and synapses. It also modulates dopamine and serotonin signaling and appears to act partly via melanocortin (MC4R) pathways. The result researched is sharper focus, memory and processing without classic stimulant jitter.
What the research & clinical use show
Semax is genuinely unusual: it's a registered drug in Russia, used clinically for ischemic stroke recovery, cognitive impairment, optic-nerve conditions and attention deficit. Russian clinical studies report improvements in memory, attention, processing speed and executive function — even in cognitively normal people — with effects building over days to weeks. The honest caveat for a Western audience: most of this evidence comes from Russian research and it hasn't been through the FDA process, so it's less familiar to US clinicians despite the real track record.
Semax dosing (research reference)
Semax is used intranasally. The literature references a cognitive-enhancement range of roughly 600–1,200 mcg/day using the 0.1% solution (about 50 mcg per drop); higher-strength 1% solutions are referenced for stroke/optic-nerve protocols. Because it's nasal, there's no injection or reconstitution for the standard cognitive use. This summarizes existing references for education only, not dosing advice.
Safety & side effects
Semax has one of the cleanest safety profiles in the neuropeptide space. Its decades of Russian pharmaceutical use — including in pediatric, stroke and healthy-adult populations — come with no major reported adverse effects and no known addictive potential or withdrawal. That's a strong record, though as always this is educational information, not medical advice, and product quality on the research market varies.
Related compounds
Semax is often discussed alongside its sister peptide Selank (an anxiolytic-leaning neuropeptide from the same Russian research lineage) and the broader nootropic family. It's a go-to for focus and neuroprotection rather than raw stimulation.
Legal & regulatory status
Semax is an approved pharmaceutical in Russia but is not FDA-approved in the US, where it's sold as a research compound (research use only). Follow the laws that apply to you.
Human clinical evidence
- The human record is Soviet and post-Soviet clinical work — real patients, real endpoints, published in Russian, and largely without the blinding, randomisation or independent replication a Western regulator would require. That is genuinely more than nothing and genuinely less than a trial, and the honest read sits between the two.
📊 Correlative data
- Registered as a medicine in Russia for stroke, transient ischaemic attack and optic nerve conditions, with Russian clinical trials behind those registrations. It is on the Russian Vital and Essential Drugs list, which is a real regulatory position even though no Western agency has assessed it.
- Widely used intranasally for focus and recovery. The reported experience is consistent — clean, non-stimulant alertness without a comedown — which is unusual enough in the anecdotal record to be worth noting.
🧪 Theoretical / extrapolated
- A fragment of ACTH (4–10) with the corticotropic activity removed, so it does not raise cortisol. It increases BDNF and NGF expression in rodent brain, which is the proposed mechanism for both the acute focus effect and the neurorestorative claims.
- The BDNF mechanism predicts a slow-building effect over weeks alongside the acute one, and it is why the Russian stroke protocols run for courses rather than single doses.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Semax — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- This class is broad, but the predicted problems cluster by mechanism rather than by molecule. Cholinergics (racetams, and anything raising acetylcholine) predict headache — the classic one, from choline demand outrunning supply. Dopaminergics and eugeroics predict tolerance, sleep disruption and a flat mood on the days off. Anything glutamatergic or AMPA-facing carries a theoretical excitotoxicity concern at high doses.
- The pattern worth internalising: anything that borrows performance from tomorrow eventually presents the bill. Sleep is the most common currency it gets paid in.
What has actually been reported
- Headache is the most reported effect across the racetam family and usually responds to added choline.
- Irritability, blunted affect and a rebound low on cessation are commonly reported with the stimulant-adjacent members.
- Most of this class has little or no controlled human safety data at the doses actually used.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Take a choline source with any racetam. The headache is the mechanism running out of substrate, and it is largely preventable rather than something to push through.
- Dose in the morning. Almost everything in this class has a longer functional tail than its half-life suggests, and sleep is the first thing you lose.
- Use them for something, not as a habit. The compounds that carry tolerance genuinely reward intermittent use aimed at a task, and genuinely punish daily use aimed at feeling normal.
- One at a time, and long enough to judge it. This is the class where people stack five and cannot tell you which one is doing anything — and the effects are subjective, so attribution is already hard enough.
- If you need it to feel normal, stop. That is the line where a tool has become a dependency, and it is the one worth watching for.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- No routine marker tracks these. Sleep is the assay — if it is degrading, the compound is costing more than it is producing, and that shows up before anything else does.
Don't run this if
- A seizure history — several of these lower the threshold at least theoretically, and it is not worth establishing empirically.
- Bipolar disorder, for the dopaminergic members especially.
- Alongside prescribed psychiatric medication without knowing exactly how the mechanisms overlap.
The honest unknown
- Chronic use is essentially uncharacterised. The specific unmeasured thing is what daily cholinergic or dopaminergic pressure does to baseline function over years — not whether a few weeks is tolerable.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Food is not a factor — pick a time you will keep
Nothing you eat touches a subcutaneous injection, so there is no meal to plan around. What does matter is a fixed slot: the commonest reason an injectable protocol underperforms is missed doses, not mistimed ones.
With a short half-life, dose it near the effect you want rather than at a fixed hour.
Derived from half-life, route and mechanism — not from a dosing trial. Reasoned, and labelled as reasoned.
Semax reconstitution calculator
Research reconstitution calculator
Where to get Semax
Buy Semax at AminoWell USA →Semax — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Semax moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Most of this class has no predicted marker movement at all, and saying so is more useful than listing markers that will not move.
What to do: A baseline liver panel is reasonable for anything taken daily and long-term. Beyond that there is nothing specific to chase.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Semax — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Semax
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anaemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 102 markers A–Z
Semax — frequently asked questions
What is Semax?
Semax is a synthetic heptapeptide nootropic derived from ACTH, registered as a pharmaceutical in Russia since 1994. It's used intranasally for cognition, focus and stroke recovery.
How does Semax work?
It rapidly upregulates BDNF and its TrkB receptor in the hippocampus and modulates dopamine/serotonin, supporting memory, attention and processing — while being engineered to drop the stress-hormone activity of its ACTH parent.
How is Semax dosed?
It's used intranasally; the literature references about 600–1,200 mcg/day for cognitive enhancement using a 0.1% solution. No injection or reconstitution for standard use. This is educational, not dosing advice.
Is Semax safe?
It has one of the cleanest records in the neuropeptide space — decades of Russian pharmaceutical use with no major reported adverse effects and no known dependence or withdrawal. Still educational only, not medical advice, and research-market purity varies.
Is Semax FDA-approved?
No. Semax is an approved drug in Russia but is not FDA-approved in the US, where it's sold as a research compound.
References & further reading
- Semax: mechanism, effects & research studies (Peptpedia)
- Semax peptide: BDNF, nootropic research and the honest science
- Semax: BDNF upregulation & safety profile
Want Coach Cam's exact Semax protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Semax is used for
Semax appears under 1 goal in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.